PUNICALAGIN-INDUCED RELEASE OF NOREPINEPHRINE REVERSES ORTHOSTATIC HYPOTENSION IN RATS

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/29829

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29829

题名:	PUNICALAGIN-INDUCED RELEASE OF NOREPINEPHRINE REVERSES ORTHOSTATIC HYPOTENSION IN RATS
作者:	CHANG, TK;HSU, FL;CHENG, JT
贡献者:	附設醫院神經部;NATL CHENG KUNG UNIV,COLL MED,DEPT PHARMACOL,TAINAN 70101,TAIWAN;CHINA MED COLL HOSP,DEPT NEUROL,TAICHUNG 40408,TAIWAN;TAIPEI MED COLL,DEPT PHARMACEUT SCI,TAIPEI 10502,TAIWAN
日期:	1994
上传时间:	2010-09-24 14:43:24 (UTC+8)
出版者:	JOHN WILEY & SONS LTD
摘要:	A series of 3',6,7-substituted 2-phenyl-4-quinolones were designed and synthesized as antimitotic antitumor agents. All compounds showed cytotoxic effects (log GI(50) less than or equal to -4.0; log drug molar concentration required to cause 50% inhibition) against the growth of a variety of human tumor cell lines, including those derived from solid tumors such as non-small cell lung, colon, central nervous system, ovary, prostate, and breast cancers, when evaluated in the National Cancer Institute's 60 human tumor cell line in vitro screen. The most potent compound (26) demonstrated strong cytotoxic effects with GI(50) values in the nanomolar or subnanomolar range in almost all the tumor cell lines. Compound 26 was also a potent inhibitor of tubulin polymerization and radiolabeled colchicine binding to tubulin, with activity comparable to those of the potent antimitotic natural products colchicine, podophyllotoxin, and combretastatin A-4.
關聯:	PHYTOTHERAPY RESEARCH 8(6):348-351
显示于类别:	[台中附設醫院] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章